FORT WORTH, Texas--(BUSINESS WIRE)--Ancor Capital Partners is pleased to announce a joint venture relationship with Little Rock, Arkansas-based Advanced Tissue, the leader in providing third-party reimbursable wound-care products in the United States.
Advanced Tissue, founded in 2000, provides advanced surgical dressings based on physician orders, in single-use unit-dose packaging, to patients in both the home as well as in long-term-care facilities. All physician-ordered wound-care supplies are customized per patient, per dressing change. Advanced Tissue simplifies and personalizes the approach to home-based dressing changes by removing the guesswork for the patient with regard to the procurement, frequency and application of the products that have been selected by their physician. This contributes to an increased positive outcome for patients that are compliant with wound-care treatments.
Tim McKibben, Ancor Managing Partner, said, “We are thrilled to partner with Advanced Tissue.” He continued, “The Advanced Tissue team has done a tremendous job building a strong and efficiently run company, and we are excited to come alongside and assist in growing Advanced Tissue to the next level. The current management team and ownership will stay in place and continue in their efforts of achieving market share in this constantly changing and growing segment of healthcare."
Kevin Lamb, Advanced Tissue CEO, said, “We are grateful to the dedicated team of employees who have helped establish Advanced Tissue as the leader in the industry and we are excited about opportunities that lie ahead.” He concluded, “With Ancor’s extensive experience in the health care industry, focus on a positive corporate culture and our continued commitment of providing wound-care products in unit-dose packaging; we believe jointly, we can dramatically grow our company.”
Yukon Partners, based in Minneapolis, provided mezzanine capital and made a minority equity interest in the transaction. “We chose Yukon Partners as our partner on the transaction due to their experience in the wound-care industry and our strong working relationship with Yukon,” said McKibben. This is the fourth investment opportunity in which Ancor and Yukon have teamed together.
About Ancor Capital Partners:
Ancor Capital Partners, based in Fort Worth, Texas, is an operations-oriented private equity firm focusing on lower middle-market manufacturing and distribution companies with EBITDA of $5-$15 million. Extensive operations experience gives the Ancor Team a unique understanding of the critical business issues faced by lower middle-market companies. Ancor’s proven track record includes 39 acquisitions to date in health care, consumer and other industries. http://www.ancorcapital.com
